IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Influenza A virus (IAV)‐induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with immunomodulatory potential, we assessed their efficacy as IAV treatments. IFNλ treatment of IAV‐infected M...
Alternative Titles
Full title
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_29e9a7e829bc409682faf9a9dbdbb308
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_29e9a7e829bc409682faf9a9dbdbb308
Other Identifiers
ISSN
1757-4676
E-ISSN
1757-4684
DOI
10.15252/emmm.201606413
